Literature DB >> 18670223

Risk factors in the development of Kaposi's sarcoma.

Rachel Colman1, David J Blackbourn.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18670223     DOI: 10.1097/QAD.0b013e3283031a9f

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion.

Authors:  L M Butler; H C Jeffery; R L Wheat; P C Rae; K Townsend; K R Alkharsah; T F Schulz; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 3.  Chronic infections with viruses or parasites: breaking bad to make good.

Authors:  Andrew Godkin; Katherine A Smith
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

Review 4.  Pulmonary involvement in Kaposi sarcoma: correlation between imaging and pathology.

Authors:  Taisa Davaus Gasparetto; Edson Marchiori; Sílvia Lourenço; Gláucia Zanetti; Alberto Domingues Vianna; Alair A S M D Santos; Luiz Felipe Nobre
Journal:  Orphanet J Rare Dis       Date:  2009-07-14       Impact factor: 4.123

5.  Functional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation.

Authors:  Zulkefley Othman; Mariam K Sulaiman; Margaret M Willcocks; Nathalie Ulryck; David J Blackbourn; Bruno Sargueil; Lisa O Roberts; Nicolas Locker
Journal:  RNA       Date:  2014-09-22       Impact factor: 4.942

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.